• 1
    Neer TM, Breitschwerdt EB, Green RT, et al. Consensus statement on ehrlichial diseases of small animals from the infectious disease study group of the ACVIM. J Vet Intern Med 2002;16:309315.
  • 2
    Harrus S, Waner T, Aizenberg I, et al. Amplification of ehrlichial DNA from dogs 34 months after infection with Ehrlichia canis. J Clin Microbiol 1998;36:7376.
  • 3
    Mylonakis ME, Koutinas AF, Breitschwerdt EB, et al. Chronic canine ehrlichiosis (Ehrlichia canis): A retrospective study of 19 natural cases. J Am Anim Hosp Assoc 2004;40:174184.
  • 4
    Mylonakis ME, Siarkou VI, Koutinas AF. Myelosuppressive canine monocytic ehrlichiosis (Ehrlichia canis): An update on the pathogenesis, diagnosis and management. Israel J Vet Med 2010;65:129135.
  • 5
    Harrus S, Kass PH, Klement E, et al. Canine monocytic ehrlichiosis: A retrospective study of 100 cases, and an epidemiological investigation of prognostic indicators for the disease. Vet Rec 1997;141:360363.
  • 6
    Shipov A, Klement E, Reuveni-Tager L, et al. Prognostic indicators for canine monocytic ehrlichiosis. Vet Parasitol 2008;153:131138.
  • 7
    Yamamoto S, Shida T, Miyaji S, et al. Changes in serum C-reactive protein levels in dogs with various disorders and surgical traumas. Vet Res Com 1993;1:8593.
  • 8
    Ceron JJ, Eckersal PD, Martinez-Subiela S. Acute phase proteins in dogs and cats: Current knowledge and future perspectives. Vet Clin Pathol 2005;34:8599.
  • 9
    Yamamoto S, Shida T, Okimura T, et al. Determination of C-reactive protein in serum and plasma from healthy dogs and dogs with pneumonia by ELISA and slide reversed passive latex agglutination test. Vet Q 1994;16:7477.
  • 10
    Eckersall PD. The time is right for acute phase protein assays. Vet J 2004;168:35.
  • 11
    Murata H, Shimada N, Yosioka M. Current research on acute phase proteins in veterinary diagnosis: An overview. Vet J 2004;168:2840.
  • 12
    Tecles F, Spiranelli E, Bonfanti U, et al. Preliminary studies of serum acute-phase protein concentrations in hematologic and neoplastic diseases of the dog. J Vet Intern Med 2005;19:865870.
  • 13
    Rikihisa Y, Yamamoto S, Kwak I, et al. C-reactive protein and α1-acid glycoprotein levels in dogs infected with Ehrlichia canis. J Clin Microbiol 1994;32:912917.
  • 14
    Shimada T, Ishida Y, Shimizu M, et al. Monitoring C-reactive protein in Beagle dogs experimentally inoculated with Ehrlichia canis. Vet Res Commun 2002;26:171177.
  • 15
    Mylonakis ME, Leontides L, Gonen L, et al. Anti-Hepatozoon canis serum antibodies and gamonts in naturally-occurring canine monocytic ehrlichiosis. Vet Parasitol 2005;129:229233.
  • 16
    Siarkou VI, Mylonakis ME, Bourtzi-Hatzopoulou E, Koutinas AF. Sequence and phylogenetic analysis of the 16S rRNA gene of Ehrlichia canis strains in dogs with clinical monocytic ehrlichiosis. Vet Microbiol 2007;125:30412.
  • 17
    Martinez-Subiela S, Ceron JJ. Validation of commercial assays for the determination of haptoglobin, C-reactive protein and serum amyloid A in dogs. Archivos de Medicina Veterinaria 2005;37:6166.
  • 18
    Neer TM, Harrus S. Canine monocytotropic ehrlichiosis and neorickettsiosis (E. canis, E. chaffeensis, E. ruminantium, N. sennetsu, and N. risticii infections). In: GreenCE, ed. Infectious Diseases of the Dog and Cat. St Louis, MO: Saunders Elsevier; 2006:203216.
  • 19
    Harrus S, Waner T, Avidar Y, et al. Serum protein alterations in canine ehrlichiosis. Vet Parasitol 1996;66:241249.
  • 20
    Martinez-Subiela S, Tecles F, Eckersall PD, et al. Serum concentrations of acute phase proteins in dogs with leishmaniasis. Vet Rec 2002;150:241244.
  • 21
    Martinez-Subiela S, Ceron JJ. Evaluation of acute phase protein indexes in dogs with leishmaniasis at diagnosis, during and after short-term treatment. Vet Med-Chech 2005;50:3946.
  • 22
    Stockham SL, Scott MA. Proteins. In: StockhamSL, ScottMA, eds. Fundamentals of Veterinary Clinical Pathology. Ames, IA: Blackwell Publishing; 2008:369413.
  • 23
    Matijatko V, Mrljak V, Kis I, et al. Evidence of an acute phase response in dogs naturally infected with Babesia canis. Vet Parasitol 2007;144:242250.
  • 24
    Yule TD, Roth MB, Dreier K, et al. Canine parvovirus vaccine elicits protection from the inflammatory and clinical consequences of the disease. Vaccine 1997;15:2029.
  • 25
    Mastrorilli C, Dondi F, Agnoli C, et al. Clinicopathologic features and outcome predictors of Leptospira interogans Australis serogroup infection in dogs: A retrospective study of 20 cases (2001–2004). J Vet Intern Med 2007;21:310.
  • 26
    Holm JL, Rosanski EA, Freeman LM, et al. C-reactive protein concentrations in dogs with acute pancreatitis. J Vet Emerg Crit Care 2004;14:183186.
  • 27
    Gebhardt C, Hirschberger J, Rau S, et al. Use of C-reactive protein to predict outcome in dogs with systemic inflammatory response syndrome or sepsis. J Vet Emerg Crit Care Med 2009;19:450458.
  • 28
    Mitchell KD, Kruth SA, Wood RD, et al. Serum acute phase protein concentrations in dogs with autoimmune haemolytic anemia. J Vet Intern Med 2009;23:585591.
  • 29
    Kocaturk M, Martinez S, Eralp O, et al. Prognostic value of serum acute-phase proteins in dogs with parvoviral enteritis. J Small Anim Pract 2010;51:478483.
  • 30
    Ishikawa S, Kayaba K, Gotoh T, et al. Comparison of C-reactive protein levels between serum and plasma samples on long-term frozen storage after a 13.8 year interval: The JMS cohort study. J Epidemiol 2007;17:120124.
  • 31
    O'Donnell A, Fowkes FJI, Allen SJ, et al. The acute phase response in children with mild and severe malaria in Papua New Guinea. Trans R Soc Trop Med Hyg 2009;103:679686.
  • 32
    Rilley RF, Zontine W. Further observations on the properties of dog C-reactive protein and the C-reactive protein response in the dog. J Lab Clin Med 1972;80:698703.